Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition
Maj-Linda B. Selenica, Leif Benner, Steven B. Housley, et al.
Alzheimer s Research & Therapy (2014) Vol. 6, Iss. 1
Open Access | Times Cited: 120

Showing 1-25 of 120 citing articles:

Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Katrina J. Falkenberg, Ricky W. Johnstone
Nature Reviews Drug Discovery (2014) Vol. 13, Iss. 9, pp. 673-691
Closed Access | Times Cited: 1377
Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects
Pascale Barbier, Orgeta Zejneli, Marlène Martinho, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 441
Histone deacetylase 6 in cancer
Ting Li, Chao Zhang, Shafat Hassan, et al.
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 279
Tubulin acetylation: responsible enzymes, biological functions and human diseases
Lin Li, Xiang-Jiao Yang
Cellular and Molecular Life Sciences (2015) Vol. 72, Iss. 22, pp. 4237-4255
Closed Access | Times Cited: 235
Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors—What Some May Have Forgotten or Would Rather Forget?
Sida Shen, Alan P. Kozikowski
ChemMedChem (2015) Vol. 11, Iss. 1, pp. 15-21
Open Access | Times Cited: 219
Histone Deacetylase 6 in Health and Disease
Carole Seidel, Michaël Schnekenburger, Mario Dicato, et al.
Epigenomics (2015) Vol. 7, Iss. 1, pp. 103-118
Closed Access | Times Cited: 197
HDAC6 as privileged target in drug discovery: A perspective
Sravani Pulya, Sk. Abdul Amin, Nilanjan Adhikari, et al.
Pharmacological Research (2020) Vol. 163, pp. 105274-105274
Closed Access | Times Cited: 185
Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies
Jakub Šinský, Karoline Pichlerová, Jozef Hanes
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9207-9207
Open Access | Times Cited: 113
Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration
Shabir Ahmad Ganai, Mahalakshmi Ramadoss, Vijayalakshmi Mahadevan
Current Neuropharmacology (2015) Vol. 14, Iss. 1, pp. 55-71
Open Access | Times Cited: 127
An acetylation–phosphorylation switch that regulates tau aggregation propensity and function
Yari Carlomagno, Dah-eun Chloe Chung, Mei Yue, et al.
Journal of Biological Chemistry (2017) Vol. 292, Iss. 37, pp. 15277-15286
Open Access | Times Cited: 118
The emerging role of peptidyl‐prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease
Laura J. Blair, Jeremy D. Baker, Jonathan J. Sabbagh, et al.
Journal of Neurochemistry (2015) Vol. 133, Iss. 1, pp. 1-13
Open Access | Times Cited: 106
The promise and perils of HDAC inhibitors in neurodegeneration
Alessandro Didonna, Puneet Opal
Annals of Clinical and Translational Neurology (2014) Vol. 2, Iss. 1, pp. 79-101
Open Access | Times Cited: 104
Posttranslational modifications of α-tubulin in alzheimer disease
Fan Zhang, Bo Su, Chunyu Wang, et al.
Translational Neurodegeneration (2015) Vol. 4, Iss. 1
Open Access | Times Cited: 104
Tau Overexpression Impacts a Neuroinflammation Gene Expression Network Perturbed in Alzheimer’s Disease
Paul D. Wes, Amy Easton, John Corradi, et al.
PLoS ONE (2014) Vol. 9, Iss. 8, pp. e106050-e106050
Open Access | Times Cited: 101
The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders
Jessica Eira, Catarina S. Silva, Mónica Mendes Sousa, et al.
Progress in Neurobiology (2016) Vol. 141, pp. 61-82
Closed Access | Times Cited: 99
Microtubule Dysfunction: A Common Feature of Neurodegenerative Diseases
Antonella Sferra, Francesco Nicita, Enrico Bertini
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7354-7354
Open Access | Times Cited: 99
An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline
Hanna Trzeciakiewicz, Deepa Ajit, Jui‐Heng Tseng, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 74
HDAC6 in Diseases of Cognition and of Neurons
Patrizia LoPresti
Cells (2020) Vol. 10, Iss. 1, pp. 12-12
Open Access | Times Cited: 71
HDAC6: A unique HDAC family member as a cancer target
Sumeet Kaur, Prerna Rajoria, Madhu Chopra
Cellular Oncology (2022) Vol. 45, Iss. 5, pp. 779-829
Closed Access | Times Cited: 56
The role of altered protein acetylation in neurodegenerative disease
Fariha Kabir, Rachel A.K. Atkinson, Anthony L. Cook, et al.
Frontiers in Aging Neuroscience (2023) Vol. 14
Open Access | Times Cited: 37
Tubulin Post-Translational Modifications: The Elusive Roles of Acetylation
Bruno Carmona, H. Susana Marinho, Catarina Lopes Matos, et al.
Biology (2023) Vol. 12, Iss. 4, pp. 561-561
Open Access | Times Cited: 25
Epigenetic Changes in Alzheimer’s Disease: DNA Methylation and Histone Modification
Laura M. De Plano, Alessandra Saitta, Salvatore Oddo, et al.
Cells (2024) Vol. 13, Iss. 8, pp. 719-719
Open Access | Times Cited: 12
The therapeutic hope for HDAC6 inhibitors in malignancy and chronic disease
Sri Nagarjun Batchu, Angela S. Brijmohan, Andrew Advani
Clinical Science (2016) Vol. 130, Iss. 12, pp. 987-1003
Closed Access | Times Cited: 83
Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer’s Disease
Obdulia Rabal, Juan A. Sánchez‐Arias, Mar Cuadrado‐Tejedor, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 19, pp. 8967-9004
Closed Access | Times Cited: 78
The Deacetylase HDAC6 Mediates Endogenous Neuritic Tau Pathology
Jui‐Heng Tseng, Ling Xie, Sheng Song, et al.
Cell Reports (2017) Vol. 20, Iss. 9, pp. 2169-2183
Open Access | Times Cited: 74
Page 1 - Next Page

Scroll to top